Spatially targeted screening to reduce tuberculosis transmission in high-incidence settings
- PMID: 30554997
- PMCID: PMC6401264
- DOI: 10.1016/S1473-3099(18)30443-2
Spatially targeted screening to reduce tuberculosis transmission in high-incidence settings
Abstract
As the leading infectious cause of death worldwide and the primary proximal cause of death in individuals living with HIV, tuberculosis remains a global concern. Existing tuberculosis control strategies that rely on passive case-finding appear insufficient to achieve targets for reductions in tuberculosis incidence and mortality. Active case-finding strategies aim to detect infectious individuals earlier in their infectious period to reduce onward transmission and improve treatment outcomes. Empirical studies of active case-finding have produced mixed results and determining how to direct active screening to those most at risk remains a topic of intense research. Our systematic review of literature evaluating the effects of geographically targeted tuberculosis screening interventions found three studies in low tuberculosis incidence settings, but none conducted in high tuberculosis incidence countries. We discuss open questions related to the use of spatially targeted approaches for active screening in countries where tuberculosis incidence is highest.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of Interests
We declare that we have no conflicts of interest.
Figures
Comment in
-
Understanding tuberculosis transmission might be the gamechanger we need.Lancet Infect Dis. 2019 Mar;19(3):e63. doi: 10.1016/S1473-3099(18)30741-2. Epub 2018 Dec 13. Lancet Infect Dis. 2019. PMID: 30554994 No abstract available.
References
-
- World Health Organization. Global Tuberculosis Report 2017 Geneva: World Health Organization, 2017.
-
- Theron G, Zijenah L, Chanda D, et al. Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial. Lancet Lond Engl 2014; 383: 424–35. - PubMed
-
- Churchyard GJ, Stevens WS, Mametja LD, et al. Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIF. Lancet Glob Health 2015; 3: e450–e457. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
